Changed Risks for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Failure to maintain the security of customer-related information or compliance with security requirements could damage the Company’s reputation with customers, cause it to incur substantial additional costs and become subject to litigation and enforcement actions

The Company’s uses of financial instruments to limit its exposure to interest rate and currency fluctuations could expose it to risks and financial losses that may adversely affect the Company’s financial condition, liquidity and results of operations

Global economic conditions and government and regulatory changes, including, but not limited to, the UK's pending exit from the European Union (EU) could adversely impact the Company’s business and results of operations

Services performed by LCD’s former nutritional chemistry and food safety business and future developments of point-of-production testing could expose the Company to various risks, including liability for errors and omissions in work conducted for LCD customers

Increased competition, including price competition, could have a material adverse effect on the Company’s revenues and profitability

Changes in payer regulations or policies (or in the interpretation of current regulations or policies), insurance regulations or approvals, or changes in other laws, regulations or policies in the United States (US), may adversely affect US governmental and third-party coverage or reimbursement for clinical laboratory testing and may have a material adverse effect upon the Company